Entering text into the input field will update the search result below
Subscribe

CTI BioPharma Q1 2023 Earnings Preview

May 10, 2023 5:35 PM ETCTI BioPharma Corp. (CTIC)By: Anuron Mitra, SA News Editor
  • CTI BioPharma (NASDAQ:CTIC) is scheduled to announce Q1 earnings results on Thursday, May 11th, after market close.
  • The consensus EPS Estimate is -$0.12 and the consensus Revenue Estimate is $22.82M (vs. $2.3M last year).
  • Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward. Revenue estimates have seen 1 upward revision and 2 downward.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.